1 Brain Metastases Treatment Drugs Market Overview 1.1 Product Overview and Scope of Brain Metastases Treatment Drugs 1.2 Brain Metastases Treatment Drugs Segment by Type 1.2.1 Global Brain Metastases Treatment Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Anticonvulsants 1.2.3 Corticosteroids 1.2.4 Chemotherapy Drugs 1.2.5 Others 1.3 Brain Metastases Treatment Drugs Segment by Application 1.3.1 Global Brain Metastases Treatment Drugs Sales Comparison by Application: (2022-2028) 1.3.2 Cancer Hospitals 1.3.3 Cancer Research Centers 1.3.4 Clinics 1.4 Global Brain Metastases Treatment Drugs Market Size Estimates and Forecasts 1.4.1 Global Brain Metastases Treatment Drugs Revenue 2017-2028 1.4.2 Global Brain Metastases Treatment Drugs Sales 2017-2028 1.4.3 Brain Metastases Treatment Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Brain Metastases Treatment Drugs Market Competition by Manufacturers 2.1 Global Brain Metastases Treatment Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Brain Metastases Treatment Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Brain Metastases Treatment Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Brain Metastases Treatment Drugs Manufacturing Sites, Area Served, Product Type 2.5 Brain Metastases Treatment Drugs Market Competitive Situation and Trends 2.5.1 Brain Metastases Treatment Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Brain Metastases Treatment Drugs Players Market Share by Revenue 2.5.3 Global Brain Metastases Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Brain Metastases Treatment Drugs Retrospective Market Scenario by Region 3.1 Global Brain Metastases Treatment Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Brain Metastases Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Brain Metastases Treatment Drugs Market Facts & Figures by Country 3.3.1 North America Brain Metastases Treatment Drugs Sales by Country 3.3.2 North America Brain Metastases Treatment Drugs Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Brain Metastases Treatment Drugs Market Facts & Figures by Country 3.4.1 Europe Brain Metastases Treatment Drugs Sales by Country 3.4.2 Europe Brain Metastases Treatment Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Brain Metastases Treatment Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Brain Metastases Treatment Drugs Sales by Region 3.5.2 Asia Pacific Brain Metastases Treatment Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Brain Metastases Treatment Drugs Market Facts & Figures by Country 3.6.1 Latin America Brain Metastases Treatment Drugs Sales by Country 3.6.2 Latin America Brain Metastases Treatment Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa Brain Metastases Treatment Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Brain Metastases Treatment Drugs Sales by Country 3.7.2 Middle East and Africa Brain Metastases Treatment Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Brain Metastases Treatment Drugs Historic Market Analysis by Type 4.1 Global Brain Metastases Treatment Drugs Sales Market Share by Type (2017-2022) 4.2 Global Brain Metastases Treatment Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Brain Metastases Treatment Drugs Price by Type (2017-2022) 5 Global Brain Metastases Treatment Drugs Historic Market Analysis by Application 5.1 Global Brain Metastases Treatment Drugs Sales Market Share by Application (2017-2022) 5.2 Global Brain Metastases Treatment Drugs Revenue Market Share by Application (2017-2022) 5.3 Global Brain Metastases Treatment Drugs Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Bayer AG 6.1.1 Bayer AG Corporation Information 6.1.2 Bayer AG Description and Business Overview 6.1.3 Bayer AG Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Bayer AG Brain Metastases Treatment Drugs Product Portfolio 6.1.5 Bayer AG Recent Developments/Updates 6.2 Pfizer Inc. 6.2.1 Pfizer Inc. Corporation Information 6.2.2 Pfizer Inc. Description and Business Overview 6.2.3 Pfizer Inc. Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Pfizer Inc. Brain Metastases Treatment Drugs Product Portfolio 6.2.5 Pfizer Inc. Recent Developments/Updates 6.3 Eli Lilly & Company 6.3.1 Eli Lilly & Company Corporation Information 6.3.2 Eli Lilly & Company Description and Business Overview 6.3.3 Eli Lilly & Company Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Eli Lilly & Company Brain Metastases Treatment Drugs Product Portfolio 6.3.5 Eli Lilly & Company Recent Developments/Updates 6.4 Novartis AG 6.4.1 Novartis AG Corporation Information 6.4.2 Novartis AG Description and Business Overview 6.4.3 Novartis AG Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Novartis AG Brain Metastases Treatment Drugs Product Portfolio 6.4.5 Novartis AG Recent Developments/Updates 6.5 Sanofi 6.5.1 Sanofi Corporation Information 6.5.2 Sanofi Description and Business Overview 6.5.3 Sanofi Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Sanofi Brain Metastases Treatment Drugs Product Portfolio 6.5.5 Sanofi Recent Developments/Updates 6.6 F. Hoffmann-La Roche Ltd. 6.6.1 F. Hoffmann-La Roche Ltd. Corporation Information 6.6.2 F. Hoffmann-La Roche Ltd. Description and Business Overview 6.6.3 F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.6.4 F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Product Portfolio 6.6.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates 6.7 AstraZeneca 6.6.1 AstraZeneca Corporation Information 6.6.2 AstraZeneca Description and Business Overview 6.6.3 AstraZeneca Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 AstraZeneca Brain Metastases Treatment Drugs Product Portfolio 6.7.5 AstraZeneca Recent Developments/Updates 6.8 GlaxoSmithKline 6.8.1 GlaxoSmithKline Corporation Information 6.8.2 GlaxoSmithKline Description and Business Overview 6.8.3 GlaxoSmithKline Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.8.4 GlaxoSmithKline Brain Metastases Treatment Drugs Product Portfolio 6.8.5 GlaxoSmithKline Recent Developments/Updates 6.9 Merck & Co., Inc. 6.9.1 Merck & Co., Inc. Corporation Information 6.9.2 Merck & Co., Inc. Description and Business Overview 6.9.3 Merck & Co., Inc. Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Merck & Co., Inc. Brain Metastases Treatment Drugs Product Portfolio 6.9.5 Merck & Co., Inc. Recent Developments/Updates 6.10 AngioChem Inc 6.10.1 AngioChem Inc Corporation Information 6.10.2 AngioChem Inc Description and Business Overview 6.10.3 AngioChem Inc Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.10.4 AngioChem Inc Brain Metastases Treatment Drugs Product Portfolio 6.10.5 AngioChem Inc Recent Developments/Updates 6.11 Mayo Clinic 6.11.1 Mayo Clinic Corporation Information 6.11.2 Mayo Clinic Brain Metastases Treatment Drugs Description and Business Overview 6.11.3 Mayo Clinic Brain Metastases Treatment Drugs Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Mayo Clinic Brain Metastases Treatment Drugs Product Portfolio 6.11.5 Mayo Clinic Recent Developments/Updates 7 Brain Metastases Treatment Drugs Manufacturing Cost Analysis 7.1 Brain Metastases Treatment Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Brain Metastases Treatment Drugs 7.4 Brain Metastases Treatment Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Brain Metastases Treatment Drugs Distributors List 8.3 Brain Metastases Treatment Drugs Customers 9 Brain Metastases Treatment Drugs Market Dynamics 9.1 Brain Metastases Treatment Drugs Industry Trends 9.2 Brain Metastases Treatment Drugs Market Drivers 9.3 Brain Metastases Treatment Drugs Market Challenges 9.4 Brain Metastases Treatment Drugs Market Restraints 10 Global Market Forecast 10.1 Brain Metastases Treatment Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Brain Metastases Treatment Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Brain Metastases Treatment Drugs by Type (2023-2028) 10.2 Brain Metastases Treatment Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Brain Metastases Treatment Drugs by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Brain Metastases Treatment Drugs by Application (2023-2028) 10.3 Brain Metastases Treatment Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Brain Metastases Treatment Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Brain Metastases Treatment Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Brain Metastases Treatment Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Brain Metastases Treatment Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Brain Metastases Treatment Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Brain Metastases Treatment Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Brain Metastases Treatment Drugs Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Brain Metastases Treatment Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Brain Metastases Treatment Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Brain Metastases Treatment Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Brain Metastases Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Brain Metastases Treatment Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Brain Metastases Treatment Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Brain Metastases Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Metastases Treatment Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Brain Metastases Treatment Drugs Sales by Region (2017-2022) & (K Units) Table 16. Global Brain Metastases Treatment Drugs Sales Market Share by Region (2017-2022) Table 17. Global Brain Metastases Treatment Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Brain Metastases Treatment Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Brain Metastases Treatment Drugs Sales by Country (2017-2022) & (K Units) Table 20. North America Brain Metastases Treatment Drugs Sales Market Share by Country (2017-2022) Table 21. North America Brain Metastases Treatment Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Brain Metastases Treatment Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Brain Metastases Treatment Drugs Sales by Country (2017-2022) & (K Units) Table 24. Europe Brain Metastases Treatment Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Brain Metastases Treatment Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Brain Metastases Treatment Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Brain Metastases Treatment Drugs Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Brain Metastases Treatment Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Brain Metastases Treatment Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Brain Metastases Treatment Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Brain Metastases Treatment Drugs Sales by Country (2017-2022) & (K Units) Table 32. Latin America Brain Metastases Treatment Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Brain Metastases Treatment Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Brain Metastases Treatment Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Brain Metastases Treatment Drugs Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Brain Metastases Treatment Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Brain Metastases Treatment Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Brain Metastases Treatment Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Brain Metastases Treatment Drugs Sales by Type (2017-2022) & (K Units) Table 40. Global Brain Metastases Treatment Drugs Sales Market Share by Type (2017-2022) Table 41. Global Brain Metastases Treatment Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Brain Metastases Treatment Drugs Revenue Share by Type (2017-2022) Table 43. Global Brain Metastases Treatment Drugs Price by Type (2017-2022) & (US$/Unit) Table 44. Global Brain Metastases Treatment Drugs Sales (K Units) by Application (2017-2022) Table 45. Global Brain Metastases Treatment Drugs Sales Market Share by Application (2017-2022) Table 46. Global Brain Metastases Treatment Drugs Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Brain Metastases Treatment Drugs Revenue Share by Application (2017-2022) Table 48. Global Brain Metastases Treatment Drugs Price by Application (2017-2022) & (US$/Unit) Table 49. Bayer AG Corporation Information Table 50. Bayer AG Description and Business Overview Table 51. Bayer AG Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Bayer AG Brain Metastases Treatment Drugs Product Table 53. Bayer AG Recent Developments/Updates Table 54. Pfizer Inc. Corporation Information Table 55. Pfizer Inc. Description and Business Overview Table 56. Pfizer Inc. Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Pfizer Inc. Brain Metastases Treatment Drugs Product Table 58. Pfizer Inc. Recent Developments/Updates Table 59. Eli Lilly & Company Corporation Information Table 60. Eli Lilly & Company Description and Business Overview Table 61. Eli Lilly & Company Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Eli Lilly & Company Brain Metastases Treatment Drugs Product Table 63. Eli Lilly & Company Recent Developments/Updates Table 64. Novartis AG Corporation Information Table 65. Novartis AG Description and Business Overview Table 66. Novartis AG Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Novartis AG Brain Metastases Treatment Drugs Product Table 68. Novartis AG Recent Developments/Updates Table 69. Sanofi Corporation Information Table 70. Sanofi Description and Business Overview Table 71. Sanofi Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Sanofi Brain Metastases Treatment Drugs Product Table 73. Sanofi Recent Developments/Updates Table 74. F. Hoffmann-La Roche Ltd. Corporation Information Table 75. F. Hoffmann-La Roche Ltd. Description and Business Overview Table 76. F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Product Table 78. F. Hoffmann-La Roche Ltd. Recent Developments/Updates Table 79. AstraZeneca Corporation Information Table 80. AstraZeneca Description and Business Overview Table 81. AstraZeneca Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. AstraZeneca Brain Metastases Treatment Drugs Product Table 83. AstraZeneca Recent Developments/Updates Table 84. GlaxoSmithKline Corporation Information Table 85. GlaxoSmithKline Description and Business Overview Table 86. GlaxoSmithKline Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. GlaxoSmithKline Brain Metastases Treatment Drugs Product Table 88. GlaxoSmithKline Recent Developments/Updates Table 89. Merck & Co., Inc. Corporation Information Table 90. Merck & Co., Inc. Description and Business Overview Table 91. Merck & Co., Inc. Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. Merck & Co., Inc. Brain Metastases Treatment Drugs Product Table 93. Merck & Co., Inc. Recent Developments/Updates Table 94. AngioChem Inc Corporation Information Table 95. AngioChem Inc Description and Business Overview Table 96. AngioChem Inc Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. AngioChem Inc Brain Metastases Treatment Drugs Product Table 98. AngioChem Inc Recent Developments/Updates Table 99. Mayo Clinic Corporation Information Table 100. Mayo Clinic Description and Business Overview Table 101. Mayo Clinic Brain Metastases Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. Mayo Clinic Brain Metastases Treatment Drugs Product Table 103. Mayo Clinic Recent Developments/Updates Table 104. Production Base and Market Concentration Rate of Raw Material Table 105. Key Suppliers of Raw Materials Table 106. Brain Metastases Treatment Drugs Distributors List Table 107. Brain Metastases Treatment Drugs Customers List Table 108. Brain Metastases Treatment Drugs Market Trends Table 109. Brain Metastases Treatment Drugs Market Drivers Table 110. Brain Metastases Treatment Drugs Market Challenges Table 111. Brain Metastases Treatment Drugs Market Restraints Table 112. Global Brain Metastases Treatment Drugs Sales Forecast by Type (2023-2028) & (K Units) Table 113. Global Brain Metastases Treatment Drugs Sales Market Share Forecast by Type (2023-2028) Table 114. Global Brain Metastases Treatment Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 115. Global Brain Metastases Treatment Drugs Revenue Market Share Forecast by Type (2023-2028) Table 116. Global Brain Metastases Treatment Drugs Sales Forecast by Application (2023-2028) & (K Units) Table 117. Global Brain Metastases Treatment Drugs Sales Market Share Forecast by Application (2023-2028) Table 118. Global Brain Metastases Treatment Drugs Revenue Forecast by Application (2023-2028) & (US$ Million) Table 119. Global Brain Metastases Treatment Drugs Revenue Market Share Forecast by Application (2023-2028) Table 120. Global Brain Metastases Treatment Drugs Sales Forecast by Region (2023-2028) & (K Units) Table 121. Global Brain Metastases Treatment Drugs Sales Market Share Forecast by Region (2023-2028) Table 122. Global Brain Metastases Treatment Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 123. Global Brain Metastases Treatment Drugs Revenue Market Share Forecast by Region (2023-2028) Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Brain Metastases Treatment Drugs Figure 2. Global Brain Metastases Treatment Drugs Market Share by Type in 2021 & 2028 Figure 3. Anticonvulsants Product Picture Figure 4. Corticosteroids Product Picture Figure 5. Chemotherapy Drugs Product Picture Figure 6. Others Product Picture Figure 7. Global Brain Metastases Treatment Drugs Market Share by Application in 2021 & 2028 Figure 8. Cancer Hospitals Figure 9. Cancer Research Centers Figure 10. Clinics Figure 11. Global Brain Metastases Treatment Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Brain Metastases Treatment Drugs Market Size (2017-2028) & (US$ Million) Figure 13. Global Brain Metastases Treatment Drugs Sales (2017-2028) & (K Units) Figure 14. Brain Metastases Treatment Drugs Sales Share by Manufacturers in 2021 Figure 15. Global Brain Metastases Treatment Drugs Revenue Share by Manufacturers in 2021 Figure 16. The Global 5 and 10 Largest Brain Metastases Treatment Drugs Players: Market Share by Revenue in 2021 Figure 17. Brain Metastases Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 18. Global Brain Metastases Treatment Drugs Sales Market Share by Region (2017-2022) Figure 19. Global Brain Metastases Treatment Drugs Sales Market Share by Region in 2021 Figure 20. Global Brain Metastases Treatment Drugs Revenue Market Share by Region (2017-2022) Figure 21. Global Brain Metastases Treatment Drugs Revenue Market Share by Region in 2021 Figure 22. United States Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Canada Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Germany Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. France Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. U.K. Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Italy Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Russia Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. China Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Japan Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. South Korea Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. India Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Australia Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. China Taiwan Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Indonesia Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Thailand Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Malaysia Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Mexico Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Brazil Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Argentina Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Colombia Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Brain Metastases Treatment Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Brain Metastases Treatment Drugs by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Brain Metastases Treatment Drugs Figure 47. Manufacturing Process Analysis of Brain Metastases Treatment Drugs Figure 48. Brain Metastases Treatment Drugs Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Bayer AG Pfizer Inc. Eli Lilly & Company Novartis AG Sanofi F. Hoffmann-La Roche Ltd. AstraZeneca GlaxoSmithKline Merck & Co., Inc. AngioChem Inc Mayo Clinic